Skip to content
Disclosery

TRV GP VI, LLC

Follow

13F filer, CIK 1990716, Boston, MA

TRV GP VI, LLC reported $64,223,946 across 4 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-08.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-007374

Period
2025-06-30
Reported value
$64.2M
Holdings
4
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000950123-25-007374, largest first. % of portfolio is the value over $64,223,946, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 3,152,456 shares; 2025Q1: 4,211,659 shares; 2025Q2: 4,211,659 shares 4,211,659$44.5M69.32%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 969,218 shares; 2025Q1: 969,218 shares; 2025Q2: 969,218 shares 969,218$11M17.16%0Timeline
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,867,119 shares; 2025Q1: 1,867,119 shares; 2025Q2: 1,867,119 shares 1,867,119$7.69M11.98%0
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 194,174 shares; 2025Q1: 194,174 shares; 2025Q2: 194,174 shares 194,174$994K1.55%0Timeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-007374 base2025-08-08acceptance time not in the bulk data set